sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Healthcare / Genome Editing

Genome Editing Market Technology (CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), TALEN (Transcriptor-Activator-Like Effector Nuclease), ZFN (Zinc Finger Nucleases), Antisense, Others), By Application (Cell Line Engineering, Genetic Engineering, and Others), and End-User (Pharmaceutical and Biotechnological Companies, Academic and Research Institutes, Contract Research Organizations): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

  • Publish On: Mar-2020
  • Total Pages: 188
  • Report Code: FAF-816
  • Base Year: 2019
  • Format:

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the genome editing industry. The report analyzes and declares the historical and current trends analysis of the genome editing industry and subsequently recommends the projected trends anticipated to be observed in the genome editing market during the upcoming years.

The genome editing market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire genome editing market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the genome editing industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the genome editing industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the genome editing market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the genome editing industry. The genome editing market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the genome editing sector. Key strategic developments in the genome editing market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the genome editing market are appropriately highlighted in the report.

The global genome editing market is experiencing significant growth that is expected to continue over the upcoming years. A massive rise in the demand for cell line engineering and genetic engineering is likely to act as a key driver of the global genome editing market.

The genome editing market research report delivers an acute valuation and taxonomy of the genome editing industry by practically splitting the market on the basis of different technology, application, end-user, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the genome editing industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the genome editing industry is provided for the leading economies of the world.

The genome editing market is segmented based on technology, application, and end-user. On the basis of technology segmentation, the market is classified into CRISPR (clustered regularly interspaced short palindromic repeats), TALEN (transcriptor-activator-like effector nuclease), ZFN (zinc finger nucleases), antisense, others. In terms of application segmentation, the market is bifurcated into genetic engineering, cell-line engineering, and others. In terms of end-user segmentation, the market is bifurcated into the pharmaceutical and biotechnological companies, academic and research institutes, contract research organizations.

Some of the essential players operating in the genome editing market, but not restricted to include Transposagen Biopharmaceuticals, Thermo Fisher Scientific, Editas Medicine, Horizon Discovery, Integrated DNA Technologies, GenScript, Lonza Group, OriGene Technologies, Sangamo BioSciences, Intellia Therapeutics, Merck, CRISPR Therapeutics and Precision BioSciences, among others.

The taxonomy of the genome editing industry by its scope and segmentation is as follows:

Global Genome Editing Market: Technology Analysis

  • CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)
  • TALEN (Transcriptor-Activator-Like Effector Nuclease)
  • ZFN (Zinc Finger Nucleases)
  • Antisense
  • Others

Global Genome Editing Market: Application Analysis

  • Cell Line Engineering
  • Genetic Engineering
  • Others

Global Genome Editing Market: End-User Analysis

  • Pharmaceutical and Biotechnological Companies
  • Academic and Research Institutes
  • Contract Research Organizations

Global Genome Editing Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises a buoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Genome Editing market – Technology Analysis
    1. 2.1. Global Genome Editing Market – Technology Overview
    2. 2.2. Global Genome Editing Market Share, by Technology, 2019 & 2026 (USD Million)
    3. 2.3. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)
      1. 2.3.1. Global CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Genome Editing Market, 2016-2026 (USD Million)
    4. 2.4. TALEN (Transcriptor-Activator-Like Effector Nuclease)
      1. 2.4.1. Global TALEN (Transcriptor-Activator-Like Effector Nuclease) Genome Editing Market, 2016-2026 (USD Million)
    5. 2.5. ZFN (Zinc Finger Nucleases)
      1. 2.5.1. Global ZFN (Zinc Finger Nucleases) Genome Editing Market, 2016-2026 (USD Million)
    6. 2.6. Antisense
      1. 2.6.1. Global Antisense Genome Editing Market, 2016-2026 (USD Million)
    7. 2.7. Others
      1. 2.7.1. Global Others Genome Editing Market, 2016-2026 (USD Million)
  3. CHAPTER 3. Genome Editing market – Application Analysis
    1. 3.1. Global Genome Editing Market – Application Overview
    2. 3.2. Global Genome Editing Market Share, by Application, 2019 & 2026 (USD Million)
    3. 3.3. Cell Line Engineering
      1. 3.3.1. Global Cell Line Engineering Genome Editing Market, 2016-2026 (USD Million)
    4. 3.4. Genetic Engineering
      1. 3.4.1. Global Genetic Engineering Genome Editing Market, 2016-2026 (USD Million)
    5. 3.5. Others
      1. 3.5.1. Global Others Genome Editing Market, 2016-2026 (USD Million)
  4. CHAPTER 4. Genome Editing market – End-User Analysis
    1. 4.1. Global Genome Editing Market – End-User Overview
    2. 4.2. Global Genome Editing Market Share, by End-User, 2019 & 2026 (USD Million)
    3. 4.3. Pharmaceutical and Biotechnological Companies
      1. 4.3.1. Global Pharmaceutical and Biotechnological Companies Genome Editing Market, 2016-2026 (USD Million)
    4. 4.4. Academic and Research Institutes
      1. 4.4.1. Global Academic and Research Institutes Genome Editing Market, 2016-2026 (USD Million)
    5. 4.5. Contract Research Organizations
      1. 4.5.1. Global Contract Research Organizations Genome Editing Market, 2016-2026 (USD Million)
  5. CHAPTER 5. Genome Editing market – Regional Analysis
    1. 5.1. Global Genome Editing Market Regional Overview
    2. 5.2. Global Genome Editing Market Share, by Region, 2019 & 2026 (Value)
    3. 5.3. North America
      1. 5.3.1. North America Genome Editing Market size and forecast, 2016-2026
      2. 5.3.2. North America Genome Editing Market, by Country, 2019 & 2026 (USD Million)
      3. 5.3.3. North America Genome Editing Market, by Technology, 2016-2026
        1. 5.3.3.1. North America Genome Editing Market, by Technology, 2016-2026 (USD Million)
      4. 5.3.4. North America Genome Editing Market, by Application, 2016-2026
        1. 5.3.4.1. North America Genome Editing Market, by Application, 2016-2026 (USD Million)
      5. 5.3.5. North America Genome Editing Market, by End-User, 2016-2026
        1. 5.3.5.1. North America Genome Editing Market, by End-User, 2016-2026 (USD Million)
      6. 5.3.6. U.S.
        1. 5.3.6.1. U.S. Market size and forecast, 2016-2026 (USD Million)
      7. 5.3.7. Canada
        1. 5.3.7.1. Canada Market size and forecast, 2016-2026 (USD Million)
    4. 5.4. Europe
      1. 5.4.1. Europe Genome Editing Market size and forecast, 2016-2026
      2. 5.4.2. Europe Genome Editing Market, by Country, 2019 & 2026 (USD Million)
      3. 5.4.3. Europe Genome Editing Market, by Technology, 2016-2026
        1. 5.4.3.1. Europe Genome Editing Market, by Technology, 2016-2026 (USD Million)
      4. 5.4.4. Europe Genome Editing Market, by Application, 2016-2026
        1. 5.4.4.1. Europe Genome Editing Market, by Application, 2016-2026 (USD Million)
      5. 5.4.5. Europe Genome Editing Market, by End-User, 2016-2026
        1. 5.4.5.1. Europe Genome Editing Market, by End-User, 2016-2026 (USD Million)
      6. 5.4.6. Germany
        1. 5.4.6.1. Germany Market size and forecast, 2016-2026 (USD Million)
      7. 5.4.7. France
        1. 5.4.7.1. France Market size and forecast, 2016-2026 (USD Million)
      8. 5.4.8. U.K.
        1. 5.4.8.1. U.K. Market size and forecast, 2016-2026 (USD Million)
      9. 5.4.9. Italy
        1. 5.4.9.1. Italy Market size and forecast, 2016-2026 (USD Million)
      10. 5.4.10. Spain
        1. 5.4.10.1. Spain Market size and forecast, 2016-2026 (USD Million)
      11. 5.4.11. Rest of Europe
        1. 5.4.11.1. Rest of Europe Market size and forecast, 2016-2026 (USD Million)
    5. 5.5. Asia Pacific
      1. 5.5.1. Asia Pacific Genome Editing Market size and forecast, 2016-2026
      2. 5.5.2. Asia Pacific Genome Editing Market, by Country, 2019 & 2026 (USD Million)
      3. 5.5.3. Asia Pacific Genome Editing Market, by Technology, 2016-2026
        1. 5.5.3.1. Asia Pacific Genome Editing Market, by Technology, 2016-2026 (USD Million)
      4. 5.5.4. Asia Pacific Genome Editing Market, by Application, 2016-2026
        1. 5.5.4.1. Asia Pacific Genome Editing Market, by Application, 2016-2026 (USD Million)
      5. 5.5.5. Asia Pacific Genome Editing Market, by End-User, 2016-2026
        1. 5.5.5.1. Asia Pacific Genome Editing Market, by End-User, 2016-2026 (USD Million)
      6. 5.5.6. China
        1. 5.5.6.1. China Market size and forecast, 2016-2026 (USD Million)
      7. 5.5.7. Japan
        1. 5.5.7.1. Japan Market size and forecast, 2016-2026 (USD Million)
      8. 5.5.8. India
        1. 5.5.8.1. India Market size and forecast, 2016-2026 (USD Million)
      9. 5.5.9. South Korea
        1. 5.5.9.1. South Korea Market size and forecast, 2016-2026 (USD Million)
      10. 5.5.10. South-East Asia
        1. 5.5.10.1. South-East Asia Market size and forecast, 2016-2026 (USD Million)
      11. 5.5.11. Rest of Asia Pacific
        1. 5.5.11.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Million)
    6. 5.6. Latin America
      1. 5.6.1. Latin America Genome Editing Market size and forecast, 2016-2026
      2. 5.6.2. Latin America Genome Editing Market, by Country, 2019 & 2026 (USD Million)
      3. 5.6.3. Latin America Genome Editing Market, by Technology, 2016-2026
        1. 5.6.3.1. Latin America Genome Editing Market, by Technology, 2016-2026 (USD Million)
      4. 5.6.4. Latin America Genome Editing Market, by Application, 2016-2026
        1. 5.6.4.1. Latin America Genome Editing Market, by Application, 2016-2026 (USD Million)
      5. 5.6.5. Latin America Genome Editing Market, by End-User, 2016-2026
        1. 5.6.5.1. Latin America Genome Editing Market, by End-User, 2016-2026 (USD Million)
      6. 5.6.6. Brazil
        1. 5.6.6.1. Brazil Market size and forecast, 2016-2026 (USD Million)
      7. 5.6.7. Mexico
        1. 5.6.7.1. Mexico Market size and forecast, 2016-2026 (USD Million)
      8. 5.6.8. Rest of Latin America
        1. 5.6.8.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Million)
    7. 5.7. The Middle-East and Africa
      1. 5.7.1. The Middle-East and Africa Genome Editing Market size and forecast, 2016-2026
      2. 5.7.2. The Middle-East and Africa Genome Editing Market, by Country, 2019 & 2026 (USD Million)
      3. 5.7.3. The Middle-East and Africa Genome Editing Market, by Technology, 2016-2026
        1. 5.7.3.1. The Middle-East and Africa Genome Editing Market, by Technology, 2016-2026 (USD Million)
      4. 5.7.4. The Middle-East and Africa Genome Editing Market, by Application, 2016-2026
        1. 5.7.4.1. The Middle-East and Africa Genome Editing Market, by Application, 2016-2026 (USD Million)
      5. 5.7.5. The Middle-East and Africa Genome Editing Market, by End-User, 2016-2026
        1. 5.7.5.1. The Middle-East and Africa Genome Editing Market, by End-User, 2016-2026 (USD Million)
      6. 5.7.6. GCC Countries
        1. 5.7.6.1. GCC Countries Market size and forecast, 2016-2026 (USD Million)
      7. 5.7.7. South Africa
        1. 5.7.7.1. South Africa Market size and forecast, 2016-2026 (USD Million)
      8. 5.7.8. Rest of Middle-East Africa
        1. 5.7.8.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Million)
  6. CHAPTER 6. Genome Editing market – Competitive Landscape
    1. 6.1. Competitor Market Share – Revenue
    2. 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 6.3. Strategic Development
      1. 6.3.1. Acquisitions and Mergers
      2. 6.3.2. New Products
      3. 6.3.3. Research & Development Activities
  7. CHAPTER 7. Company Profiles
    1. 7.1. Thermo Fisher Scientific
      1. 7.1.1. Company Overview
      2. 7.1.2. Thermo Fisher Scientific Revenue and Gross Margin
      3. 7.1.3. Product portfolio
      4. 7.1.4. Recent initiatives
    2. 7.2. Transposagen Biopharmaceuticals
      1. 7.2.1. Company Overview
      2. 7.2.2. Transposagen Biopharmaceuticals Revenue and Gross Margin
      3. 7.2.3. Product portfolio
      4. 7.2.4. Recent initiatives
    3. 7.3. Horizon Discovery
      1. 7.3.1. Company Overview
      2. 7.3.2. Horizon Discovery Revenue and Gross Margin
      3. 7.3.3. Product portfolio
      4. 7.3.4. Recent initiatives
    4. 7.4. Editas Medicine
      1. 7.4.1. Company Overview
      2. 7.4.2. Editas Medicine Revenue and Gross Margin
      3. 7.4.3. Product portfolio
      4. 7.4.4. Recent initiatives
    5. 7.5. GenScript
      1. 7.5.1. Company Overview
      2. 7.5.2. GenScript Revenue and Gross Margin
      3. 7.5.3. Product portfolio
      4. 7.5.4. Recent initiatives
    6. 7.6. Integrated DNA Technologies
      1. 7.6.1. Company Overview
      2. 7.6.2. Integrated DNA Technologies Revenue and Gross Margin
      3. 7.6.3. Product portfolio
      4. 7.6.4. Recent initiatives
    7. 7.7. Sangamo BioSciences
      1. 7.7.1. Company Overview
      2. 7.7.2. Sangamo BioSciences Revenue and Gross Margin
      3. 7.7.3. Product portfolio
      4. 7.7.4. Recent initiatives
    8. 7.8. Lonza Group
      1. 7.8.1. Company Overview
      2. 7.8.2. Lonza Group Revenue and Gross Margin
      3. 7.8.3. Product portfolio
      4. 7.8.4. Recent initiatives
    9. 7.9. OriGene Technologies
      1. 7.9.1. Company Overview
      2. 7.9.2. OriGene Technologies Revenue and Gross Margin
      3. 7.9.3. Product portfolio
      4. 7.9.4. Recent initiatives
    10. 7.10. Merck
      1. 7.10.1. Company Overview
      2. 7.10.2. Merck Revenue and Gross Margin
      3. 7.10.3. Product portfolio
      4. 7.10.4. Recent initiatives
    11. 7.11. Intellia Therapeutics
      1. 7.11.1. Company Overview
      2. 7.11.2. Intellia Therapeutics Revenue and Gross Margin
      3. 7.11.3. Product portfolio
      4. 7.11.4. Recent initiatives
    12. 7.12. CRISPR Therapeutics
      1. 7.12.1. Company Overview
      2. 7.12.2. CRISPR Therapeutics Revenue and Gross Margin
      3. 7.12.3. Product portfolio
      4. 7.12.4. Recent initiatives
    13. 7.13. Precision BioSciences
      1. 7.13.1. Company Overview
      2. 7.13.2. Precision BioSciences Revenue and Gross Margin
      3. 7.13.3. Product portfolio
      4. 7.13.4. Recent initiatives
  8. CHAPTER 8. Genome Editing — Industry Analysis
    1. 8.1. Genome Editing Market – Key Trends
      1. 8.1.1. Market Drivers
      2. 8.1.2. Market Restraints
      3. 8.1.3. Market Opportunities
    2. 8.2. Value Chain Analysis
    3. 8.3. Technology Roadmap and Timeline
    4. 8.4. Genome Editing Market – Attractiveness Analysis
      1. 8.4.1. By Technology
      2. 8.4.2. By Application
      3. 8.4.3. By End-User
      4. 8.4.4. By Region
  9. CHAPTER 9. Marketing Strategy Analysis, Distributors
    1. 9.1. Marketing Channel
    2. 9.2. Direct Marketing
    3. 9.3. Indirect Marketing
    4. 9.4. Marketing Channel Development Trend
    5. 9.5. Economic/Political Environmental Change
  10. CHAPTER 10. Report Conclusion
  11. CHAPTER 11. Research Approach & Methodology
    1. 11.1. Report Description
    2. 11.2. Research Scope
    3. 11.3. Research Methodology
      1. 11.3.1. Secondary Research
      2. 11.3.2. Primary Research
      3. 11.3.3. Models
        1. 11.3.3.1. Company Share Analysis Model
        2. 11.3.3.2. Revenue Based Modeling
        3. 11.3.3.3. Research Limitations

        List of Figures

        FIG. 1 Global Genome Editing Market, 2016-2026 (USD Million)
        FIG. 2 Global Genome Editing Market Share, by Technology, 2019 & 2026 (USD Million)
        FIG. 3 Global CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Genome Editing Market, 2016-2026 (USD Million)
        FIG. 4 Global TALEN (Transcriptor-Activator-Like Effector Nuclease) Genome Editing Market, 2016-2026 (USD Million)
        FIG. 5 Global ZFN (Zinc Finger Nucleases) Genome Editing Market, 2016-2026 (USD Million)
        FIG. 6 Global Antisense Genome Editing Market, 2016-2026 (USD Million)
        FIG. 7 Global Others Genome Editing Market, 2016-2026 (USD Million)
        FIG. 8 Global Genome Editing Market Share, by Application, 2019 & 2026 (USD Million)
        FIG. 9 Global Cell Line Engineering Genome Editing Market, 2016-2026 (USD Million)
        FIG. 10 Global Genetic Engineering Genome Editing Market, 2016-2026 (USD Million)
        FIG. 11 Global Others Genome Editing Market, 2016-2026 (USD Million)
        FIG. 12 Global Genome Editing Market Share, by End-User, 2019 & 2026 (USD Million)
        FIG. 13 Global Pharmaceutical and Biotechnological Companies Genome Editing Market, 2016-2026 (USD Million)
        FIG. 14 Global Academic and Research Institutes Genome Editing Market, 2016-2026 (USD Million)
        FIG. 15 Global Contract Research Organizations Genome Editing Market, 2016-2026 (USD Million)
        FIG. 16 Global Genome Editing Market Share, by Region, 2019 & 2026
        FIG. 17 North America Genome Editing Market, 2016-2026
        FIG. 18 U.S. Genome Editing Market, 2016-2026
        FIG. 19 Canada Genome Editing Market, 2016-2026
        FIG. 20 Europe Genome Editing Market, 2016-2026
        FIG. 21 Germany Genome Editing Market, 2016-2026
        FIG. 22 France Genome Editing Market, 2016-2026
        FIG. 23 U.K. Genome Editing Market, 2016-2026
        FIG. 24 Italy Genome Editing Market, 2016-2026
        FIG. 25 Spain Genome Editing Market, 2016-2026
        FIG. 26 Rest of Europe Genome Editing Market, 2016-2026
        FIG. 27 Asia Pacific Genome Editing Market, 2016-2026
        FIG. 28 China Genome Editing Market, 2016-2026
        FIG. 29 Japan Genome Editing Market, 2016-2026
        FIG. 30 India Genome Editing Market, 2016-2026
        FIG. 31 South  Korea Genome Editing Market, 2016-2026
        FIG. 32 South-East Asia Genome Editing Market, 2016-2026
        FIG. 33 Rest of Asia Pacific Genome Editing Market, 2016-2026
        FIG. 34 Latin America Genome Editing Market, 2016-2026
        FIG. 35 Brazil Genome Editing Market, 2016-2026
        FIG. 36 Mexico Genome Editing Market, 2016-2026
        FIG. 37 Rest of Latin America Genome Editing Market, 2016-2026
        FIG. 38 The Middle-East and Africa Genome Editing Market, 2016-2026
        FIG. 39 GCC Countries Genome Editing Market, 2016-2026
        FIG. 40 South Africa Genome Editing Market, 2016-2026
        FIG. 41 Rest of Middle-East Africa Genome Editing Market, 2016-2026
        FIG. 42 Competitor Market Share – Revenue
        FIG. 43 Thermo Fisher Scientific Revenue and Growth Rate
        FIG. 44 Thermo Fisher Scientific Market Share
        FIG. 45 Transposagen Biopharmaceuticals Revenue and Growth Rate
        FIG. 46 Transposagen Biopharmaceuticals Market Share
        FIG. 47 Horizon Discovery Revenue and Growth Rate
        FIG. 48 Horizon Discovery Market Share
        FIG. 49 Editas Medicine Revenue and Growth Rate
        FIG. 50 Editas Medicine Market Share
        FIG. 51 GenScript Revenue and Growth Rate
        FIG. 52 GenScript Market Share
        FIG. 53 Integrated DNA Technologies Revenue and Growth Rate
        FIG. 54 Integrated DNA Technologies Market Share
        FIG. 55 Sangamo BioSciences Revenue and Growth Rate
        FIG. 56 Sangamo BioSciences Market Share
        FIG. 57 Lonza Group Revenue and Growth Rate
        FIG. 58 Lonza Group Market Share
        FIG. 59 OriGene Technologies Revenue and Growth Rate
        FIG. 60 OriGene Technologies Market Share
        FIG. 61 Merck Revenue and Growth Rate
        FIG. 62 Merck Market Share
        FIG. 63 Intellia Therapeutics Revenue and Growth Rate
        FIG. 64 Intellia Therapeutics Market Share
        FIG. 65 CRISPR Therapeutics Revenue and Growth Rate
        FIG. 66 CRISPR Therapeutics Market Share
        FIG. 67 Precision BioSciences Revenue and Growth Rate
        FIG. 68 Precision BioSciences Market Share
        FIG. 69 Market Dynamics
        FIG. 70 Global Genome Editing – Value Chain Analysis
        FIG. 71 Technology Roadmap and Timeline
        FIG. 72 Market Attractiveness Analysis – By Technology
        FIG. 73 Market Attractiveness Analysis – By Application
        FIG. 74 Market Attractiveness Analysis – By End-User
        FIG. 75 Market Attractiveness Analysis – By Region
        FIG. 76 Market Channel
        FIG. 77 Marketing Channel Development Trend
        FIG. 78 Growth in World Gross Product, 2008-2018

        List of Tables

        TABLE 1 Global Genome Editing Market, 2019 & 2026 (USD Million)
        TABLE 2 Global Genome Editing market, by Technology, 2016-2026 (USD Million)
        TABLE 3 Global Genome Editing market, by Application, 2016-2026 (USD Million)
        TABLE 4 Global Genome Editing market, by End-User, 2016-2026 (USD Million)
        TABLE 5 Global Genome Editing market, by Region, 2016-2026 (USD Million)
        TABLE 6 North America Genome Editing Market, by Technology, 2016-2026 (USD Million)
        TABLE 7 North America Genome Editing Market, by Application, 2016-2026 (USD Million)
        TABLE 8 North America Genome Editing Market, by End-User, 2016-2026 (USD Million)
        TABLE 9 Europe Genome Editing Market, by Technology, 2016-2026 (USD Million)
        TABLE 10 Europe Genome Editing Market, by Application, 2016-2026 (USD Million)
        TABLE 11 Europe Genome Editing Market, by End-User, 2016-2026 (USD Million)
        TABLE 12 Asia Pacific Genome Editing Market, by Technology, 2016-2026 (USD Million)
        TABLE 13 Asia Pacific Genome Editing Market, by Application, 2016-2026 (USD Million)
        TABLE 14 Asia Pacific Genome Editing Market, by End-User, 2016-2026 (USD Million)
        TABLE 15 Latin America Genome Editing Market, by Technology, 2016-2026 (USD Million)
        TABLE 16 Latin America Genome Editing Market, by Application, 2016-2026 (USD Million)
        TABLE 17 Latin America Genome Editing Market, by End-User, 2016-2026 (USD Million)
        TABLE 18 The Middle-East and Africa Genome Editing Market, by Technology, 2016-2026 (USD Million)
        TABLE 19 The Middle-East and Africa Genome Editing Market, by Application, 2016-2026 (USD Million)
        TABLE 20 The Middle-East and Africa Genome Editing Market, by End-User, 2016-2026 (USD Million)
        TABLE 21 Global Genome Editing Market - Company Revenue Analysis 2016-2019 (USD Million)
        TABLE 22 Global Genome Editing Market - Company Revenue Share Analysis 2016-2019(%)
        TABLE 23 Acquisitions and Mergers
        TABLE 24 New Product/Service Launch
        TABLE 25 Research & Development Activities
        TABLE 26 Market Drivers
        TABLE 27 Market Restraints
        TABLE 28 Market Opportunities
        

Key Insights from Primary Research

  • As per our primary respondents, the China genome editing market is set to grow annually at a rate of around 16.0%
  • It was established through primary research that the China genome editing market was valued at more than USD 300.00 million in 2019
  • The robust industrialization in China is supposed to display the highest growth in the regional market as it is one of the developed economies.
  • Increase investment in the healthcare sector is supposed to fuel market growth. The companies are supposed to invest in R&D to innovate the better product. Product invention will open new opportunities for the genome editing thus is expected to propel the industry demand in the upcoming years.
  • The “CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)” category, on the basis of technology segmentation, was the leading revenue-generating category accounting for more than 30.0% share, in 2019.
  • The “Cell Line Engineering” category, on the basis of application segmentation, was the leading revenue-generating category accounting for more than 40.0% share, in 2019.
  • The “Pharmaceutical and Biotechnological Companies” category, on the basis of end-user segmentation, was the leading revenue-generating category accounting for more than 40.0% share, in 2019.

Key Recommendations from Analysts

  • There is a huge demand for genome editing in developing regions such as the Asia Pacific, which is driving the healthcare industry in the regions.
  • North America region is anticipated to a larger share of the genome editing market in the upcoming years.
  • India's genome editing market is anticipated to rise at the highest rate between 2020 and 2026.
  • Growing at a CAGR around 16.0%, China genome editing and mining market provides numerous opportunities for all of the involved stakeholders across the entire value chain
  • Our analysts have identified “CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)”, “Cell Line Engineering” and “Pharmaceutical and Biotechnological Companies” categories as the leading investment pockets for genome editing market in terms of technology, application, and end-user segmentations respectively

Global Genome Editing Market Revenue Share in 2019 – By End-User

Genome Editing Market

Industry Major Market Players

  •  Transposagen Biopharmaceuticals
  •  Thermo Fisher Scientific
  •  Editas Medicine
  •  Horizon Discovery
  •  Integrated DNA Technologies
  •  GenScript
  •  Lonza Group
  •  OriGene Technologies
  •  Sangamo BioSciences
  •  Intellia Therapeutics
  •  Merck
  •  CRISPR Therapeutics 
  •  Precision BioSciences

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions